<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="case-report" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Bone Rep</journal-id>
<journal-id journal-id-type="iso-abbrev">Bone Rep</journal-id>
<journal-title-group>
<journal-title>Bone Reports</journal-title>
</journal-title-group>
<issn pub-type="epub">2352-1872</issn>
<publisher>
<publisher-name>Elsevier</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30364642</article-id>
<article-id pub-id-type="pmc">6197702</article-id>
<article-id pub-id-type="publisher-id">S2352-1872(18)30048-2</article-id>
<article-id pub-id-type="doi">10.1016/j.bonr.2018.09.001</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Skeletal disease in a father and daughter with a novel monoallelic WNT1 mutation</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Ang</surname>
<given-names>Kathleen</given-names>
</name>
<email>Kathleen.ang@yale.edu</email>
<xref ref-type="corresp" rid="cr0005">⁎</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sanchez Rangel</surname>
<given-names>Elizabeth</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yuan</surname>
<given-names>Qianying</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wu</surname>
<given-names>Dianqing</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Carpenter</surname>
<given-names>Thomas O.</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Insogna</surname>
<given-names>Karl</given-names>
</name>
</contrib>
</contrib-group>
<aff id="af0005">Yale University School of Medicine, New Haven, CT, United States of America</aff>
<author-notes>
<corresp id="cr0005"><label>⁎</label>Corresponding author. <email>Kathleen.ang@yale.edu</email></corresp>
</author-notes>
<pub-date pub-type="pmc-release">
<day>19</day>
<month>9</month>
<year>2018</year>
</pub-date>
<!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.-->
<pub-date pub-type="collection">
<month>12</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>19</day>
<month>9</month>
<year>2018</year>
</pub-date>
<volume>9</volume>
<fpage>154</fpage>
<lpage>158</lpage>
<history>
<date date-type="received">
<day>17</day>
<month>7</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>14</day>
<month>9</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>© 2018 The Authors</copyright-statement>
<copyright-year>2018</copyright-year>
<license license-type="CC BY-NC-ND" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/">
<license-p>This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).</license-p>
</license>
</permissions>
<abstract id="ab0005">
<sec>
<title>Context</title>
<p>Most heritable causes of low bone mass in children occur due to mutations affecting type 1 collagen. We describe two related patients with low bone mass and fracture without mutations in the type 1 collagen genes.</p>
</sec>
<sec>
<title>Case description</title>
<p>We describe the index case of a 10-year-old girl with low-impact fractures in childhood and her 59-year-old father with traumatic fractures in adulthood, both with low bone mineral density. They were found to have the same heterozygous missense mutation in the WNT1 gene (p.Gly222Arg), occurring in a highly conserved WNT motif in close proximity to the Frizzled binding site.</p>
</sec>
<sec>
<title>Conclusions</title>
<p>The WNT-ligand WNT1, signaling through the canonical WNT-β­catenin pathway, plays a critical role in skeletal development, adult skeletal homeostasis, and bone remodeling. Biallelic mutations have been described and are associated with moderate to severe osteogenesis imperfecta, in some cases with extra-skeletal manifestations. Patients with monoallelic mutations, as in our case, seem to present with low bone mineral density and less severe disease. The phenotypic difference between biallelic and monoallelic mutations highlights that the aberrant protein in monoallelic mutations may exert a dominant negative effect on the wild type protein as heterozygous carriers in families with biallelic disease are usually asymptomatic. With better understanding of disorders associated with WNT1 mutations, therapies targeting this signaling pathway may offer therapeutic benefit.</p>
</sec>
</abstract>
<kwd-group id="ks0005">
<title>Keywords</title>
<kwd>Osteopenia</kwd>
<kwd>fracture</kwd>
<kwd>Monoallelic mutation</kwd>
<kwd>Biallelic mutation</kwd>
<kwd>WNT1 mutation</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="s0005">
<label>1</label>
<title>Introduction</title>
<p id="p0485">The most frequently encountered heritable disorder of low bone mass in children is osteogenesis imperfecta (OI) (<xref ref-type="bibr" rid="bb0055">Makitie et al., 2016</xref>). OI types I-IV occur due to mutations in the COL1A1 or COL1A2 gene, affecting type 1 collagen and altering matrix structure, resulting in low bone mass and fragility fracture. In this report, we describe the index case of a 10-year-old girl with osteoporosis without mutations in the type 1 collagen genes as well as findings in her 59-year-old father.</p>
</sec>
<sec id="s0010">
<label>2</label>
<title>Case report</title>
<p id="p0490">A 10-year-old girl presented with a history of multiple fractures over the previous year. Her gestation and delivery were uncomplicated, and she reached developmental milestones normally. At age 9, she sustained a right metatarsal fracture resulting from direct trauma to her foot. Five months later, she sustained a right distal radius fracture after falling on her outstretched hand. Two weeks prior to evaluation, she experienced sudden back spasm while brushing her hair, followed by acute back pain. She was evaluated in an emergency department and found to have marked osteopenia of her vertebral bodies, but no fracture. When seen at Yale, she reported a two-year history of back pain, exacerbated by jumping. Her diet contained approximately 400 mg/day of calcium. At initial evaluation, her height was at the 85th percentile and weight at the 61st percentile. She appeared healthy, was premenarchal, was wearing a back brace, and using a wheelchair. Physical examination revealed normal strength and normal range of motion at all joints. Her sclerae were white and her dentition was normal. The initial laboratory evaluation is summarized in <xref ref-type="table" rid="t0005">Table 1</xref> and was unremarkable except for an extremely low L-spine BMD.<table-wrap id="t0005" position="float"><label>Table 1</label><caption><p>Laboratory and DXA evaluation.</p></caption><alt-text id="al0010">Table 1</alt-text><table frame="hsides" rules="groups"><thead><tr><th></th><th></th><th>Initial Evaluation</th><th>Reference Range</th><th>Post-Treatment</th></tr></thead><tbody><tr><td rowspan="8">Proband</td><td>Calcium</td><td>10.2 mg/dL</td><td>8.8–10.2</td><td>9.3 mg/dL</td></tr><tr><td>Phosphorus</td><td>4.2 mg/dL</td><td>3.5–5.6</td><td>4.3 mg/dL</td></tr><tr><td>Alkaline Phosphatase</td><td>177 U/L</td><td>50–480</td><td>219 U/L</td></tr><tr><td>Collage Type I C-Telopeptide</td><td>934 pg/mL</td><td>519–2415</td><td>957 pg/mL</td></tr><tr><td>Parathyroid hormone, (mid molecule assay)</td><td>9 nLEq/mL</td><td>10–25</td><td>26 nL Eq/mL</td></tr><tr><td>25-Hydroxy Vitamin D</td><td>31 ng/mL</td><td>20–50</td><td>26 ng/mL</td></tr><tr><td>L-spine, BMD (by DXA)</td><td>0.349 g/cm<sup>2</sup></td><td></td><td>0.489 g/cm2</td></tr><tr><td>L-spine, <italic>Z</italic>-score (by DXA)</td><td>−4.7</td><td></td><td>−2.9</td></tr><tr><td rowspan="2">Father</td><td>L-spine, BMD (by DXA)</td><td>0.853 g/cm<sup>2</sup></td><td></td><td></td></tr><tr><td>L-spine, T-score (by DXA)</td><td>−2.2</td><td></td><td></td></tr></tbody></table><table-wrap-foot><fn><p>Laboratory and DXA results of the proband and her father at initial evaluation and post-treatment.</p></fn></table-wrap-foot></table-wrap></p>
<p id="p0495">Whole exome sequencing revealed a heterozygous mutation (p.Gly222Arg) in the WNT1 gene. She was treated with zoledronic acid infusions 0.0125 mg/kg every 3 months for two doses, then 0.05 mg/kg every 6 months thereafter. A dietary Ca of 1200 mg/d was recommended. She enrolled in an intensive physical therapy program with marked improvement, progressing to ambulation with walker. After 1 year of zoledronic acid infusions, she was able run and participate in physical education. She gained approximately 5 cm in height during the first year of treatment. She did not reach menarche while on zoledronic acid infusions. Bone mineral density, although low for age, improved considerably over the year (<xref ref-type="table" rid="t0005">Table 1</xref>).</p>
<p id="p0500">Subsequent evaluation of the patient's 59-year old father revealed the same WNT1 mutation. He had sustained multiple finger fractures as a child and bilateral hand fractures while playing basketball in college. On initial evaluation, he was well-appearing, his vital signs were normal and his height was 6′3″, weight 208 pounds, BMI 26 kg/m<sup>2</sup>. Physical examination was unremarkable with normal arm span, joints, and virilization. Sclerae were white and his dentition was normal. An extensive evaluation for secondary causes of bone loss was unrevealing. Further evaluation revealed low bone mineral density in the lumbar spine and normal spinal radiographs. Since he had no recent fractures, anti-osteoporotic therapy was not initiated.</p>
</sec>
<sec id="s0015">
<label>3</label>
<title>Discussion</title>
<p id="p0505">Loss of function mutations in the WNT-ligand, WNT1, have been associated with a spectrum of skeletal dysplasias (<xref ref-type="bibr" rid="bb0050">Laine et al., 2013</xref>). The WNT gene family encodes signaling proteins that act in several crucial developmental and regenerative processes (<xref ref-type="bibr" rid="bb0015">Baron and Kneissel, 2013</xref>). The canonical WNT–β­catenin signaling pathway is required for skeletal development, homeostasis, and remodeling. This pathway is activated by interaction of a WNT ligand with the transmembrane receptor Frizzled, and a co-receptor, LDL-receptor related protein (LRP). Ligand binding leads to accumulation of intracellular β-catenin, which translocates to the nucleus where, in association with transcription factor 4 (TCF­4) or lymphoid enhancer­ binding factor 1 (LEF­1), it regulates a wide array of genes in a tissue-specific manner, and in bone, leads to increased formation and reduced resorption (<xref ref-type="bibr" rid="bb0010">van Amerongen et al., 2008</xref>).</p>
<p id="p0510">Initial reports of OI secondary to WNT1 mutations were associated with an autosomal recessive inheritance pattern (<xref ref-type="bibr" rid="bb0050">Laine et al., 2013</xref>; <xref ref-type="bibr" rid="bb0035">Keupp et al., 2013</xref>; <xref ref-type="bibr" rid="bb0060">Pyott et al., 2013</xref>; <xref ref-type="bibr" rid="bb0025">Fahiminiya et al., 2013</xref>; <xref ref-type="bibr" rid="bb0005">Aldinger et al., 2016</xref>; <xref ref-type="bibr" rid="bb0030">Faqeih et al., 2013</xref>; <xref ref-type="bibr" rid="bb0070">Won et al., 2017</xref>; <xref ref-type="bibr" rid="bb0065">Stephen et al., 2015</xref>). Phenotypically, they manifested with moderate to severe OI (<xref ref-type="table" rid="t0010">Table 2</xref>). Several patients also developed extra-skeletal manifestations, including neurologic and developmental abnormalities. A particularly severe phenotype was described in 2 sisters of a Lao Hmong family with severe osteopenia, fractures in utero, and long bone deformities (<xref ref-type="bibr" rid="bb0050">Laine et al., 2013</xref>).<table-wrap id="t0010" position="float"><label>Table 2</label><caption><p>Summary of WNT1 mutations.</p></caption><alt-text id="al0015">Table 2</alt-text><table frame="hsides" rules="groups"><thead><tr><th></th><th>Reference</th><th>Gene mutation</th><th>Phenotype</th></tr></thead><tbody><tr><td rowspan="3">Monoallelic mutations</td><td>Proband and her father</td><td>c.666G&gt;A(p.Gly222Arg)</td><td><list id="l0005" list-type="simple"><list-item id="li0005"><label>•</label><p id="p0005">1 male, 1 female</p></list-item><list-item id="li0010"><label>•</label><p id="p0010">Recurrent traumatic fractures</p></list-item><list-item id="li0015"><label>•</label><p id="p0015">Low bone mineral density</p></list-item></list></td></tr><tr><td><xref ref-type="bibr" rid="bb0035">Keupp et al. (2013)</xref></td><td>c.703C &gt; T (p.Arg235Trp)</td><td><list id="l0010" list-type="simple"><list-item id="li0020"><label>•</label><p id="p0020">2 males, 3 females</p></list-item><list-item id="li0025"><label>•</label><p id="p0025">Recurrent fractures of vertebrae and ribs beginning in adolescence</p></list-item><list-item id="li0030"><label>•</label><p id="p0030">Low-bone-turn- over markers, and a reduction of trabecular and cortical bone</p></list-item></list></td></tr><tr><td><xref ref-type="bibr" rid="bb0050">Laine et al. (2013)</xref></td><td>c.652 T &gt; G (p.Cys218Gly)</td><td><list id="l0015" list-type="simple"><list-item id="li0035"><label>•</label><p id="p0035">4 males, 6 females</p></list-item><list-item id="li0040"><label>•</label><p id="p0040">Severe early-onset osteoporosis</p></list-item><list-item id="li0045"><label>•</label><p id="p0045">Low-impact vertebral and peripheral</p></list-item><list-item id="li0050"><label>•</label><p id="p0050">fractures</p></list-item></list></td></tr><tr><td rowspan="4">Compound mutations</td><td><xref ref-type="bibr" rid="bb0025">Fahiminiya et al. (2013)</xref></td><td>c.946_949insAACA (p.Ser317Lysfs) and c.1063G &gt; T (p.Val355Phe)</td><td><list id="l0020" list-type="simple"><list-item id="li0055"><label>•</label><p id="p0055">1 female</p></list-item><list-item id="li0060"><label>•</label><p id="p0060">Short stature</p></list-item><list-item id="li0065"><label>•</label><p id="p0065">Low bone density</p></list-item><list-item id="li0070"><label>•</label><p id="p0070">Severe vertebral compression fractures</p></list-item><list-item id="li0075"><label>•</label><p id="p0075">Multiple long bone fractures</p></list-item></list></td></tr><tr><td><xref ref-type="bibr" rid="bb0060">Pyott et al. (2013)</xref></td><td>c.506dupG (p.Cys170Leufs*6) and c.259C &gt; T (p.Gln87*)</td><td><list id="l0025" list-type="simple"><list-item id="li0080"><label>•</label><p id="p0080">1 male</p></list-item><list-item id="li0085"><label>•</label><p id="p0085">Multiple fractures</p></list-item><list-item id="li0090"><label>•</label><p id="p0090">Poor feeding</p></list-item><list-item id="li0095"><label>•</label><p id="p0095">Delayed development</p></list-item><list-item id="li0100"><label>•</label><p id="p0100">Recurrent infections</p></list-item></list></td></tr><tr><td>Aldinger Et al (2016)</td><td>c.184C &gt; T (p.Gln62*) and c.677C &gt; T (p.Ser226Leu)</td><td><list id="l0030" list-type="simple"><list-item id="li0105"><label>•</label><p id="p0105">4 males, 2 females</p></list-item><list-item id="li0110"><label>•</label><p id="p0110">Multiple fractures</p></list-item><list-item id="li0115"><label>•</label><p id="p0115">Bone deformities</p></list-item><list-item id="li0120"><label>•</label><p id="p0120">Intellectual disability</p></list-item><list-item id="li0125"><label>•</label><p id="p0125">Neurological abnormalities including seizures, absence of speech, and inability to feed</p></list-item><list-item id="li0130"><label>•</label><p id="p0130">Brainstem and cerebellar hypoplasia</p></list-item></list></td></tr><tr><td>Yeon <xref ref-type="bibr" rid="bb0070">Won et al. (2017)</xref></td><td>c.369A &gt; C (p.Glu123Asp) and c.457 T &gt; G (p.Cys153Gly)</td><td><list id="l0035" list-type="simple"><list-item id="li0135"><label>•</label><p id="p0135">1 female</p></list-item><list-item id="li0140"><label>•</label><p id="p0140">Early onset recurrent fractures of vertebrae and extremities</p></list-item><list-item id="li0145"><label>•</label><p id="p0145">Bone deformity</p></list-item><list-item id="li0150"><label>•</label><p id="p0150">Short stature</p></list-item></list></td></tr><tr><td rowspan="13">Biallelic Mutations</td><td><xref ref-type="bibr" rid="bb0035">Keupp et al. (2013)</xref></td><td>c.859dupC (p.His287Profs*30)</td><td><list id="l0040" list-type="simple"><list-item id="li0155"><label>•</label><p id="p0155">2 males, 1 female</p></list-item><list-item id="li0160"><label>•</label><p id="p0160">Early onset recurrent fractures of extremities</p></list-item><list-item id="li0165"><label>•</label><p id="p0165">Bone deformity</p></list-item><list-item id="li0170"><label>•</label><p id="p0170">Reduction of bone density</p></list-item><list-item id="li0175"><label>•</label><p id="p0175">Short stature</p></list-item><list-item id="li0180"><label>•</label><p id="p0180">Bluish sclera in some affected individuals</p></list-item></list></td></tr><tr><td></td><td>c.529G &gt; T (p.Gly177Cys)</td><td><list id="l0045" list-type="simple"><list-item id="li0185"><label>•</label><p id="p0185">1 female</p></list-item><list-item id="li0190"><label>•</label><p id="p0190">Early onset recurrent fractures of vertebrae and extremities</p></list-item><list-item id="li0195"><label>•</label><p id="p0195">Bone deformity</p></list-item><list-item id="li0200"><label>•</label><p id="p0200">Short stature</p></list-item><list-item id="li0205"><label>•</label><p id="p0205">Blue sclera</p></list-item></list></td></tr><tr><td></td><td>c.624 + 4A &gt; G</td><td><list id="l0050" list-type="simple"><list-item id="li0210"><label>•</label><p id="p0210">1 male</p></list-item><list-item id="li0215"><label>•</label><p id="p0215">Multiple fractures of vertebrae and extremities</p></list-item><list-item id="li0220"><label>•</label><p id="p0220">Bone deformity</p></list-item><list-item id="li0225"><label>•</label><p id="p0225">Short stature</p></list-item></list></td></tr><tr><td></td><td>c.565G &gt; T (p.Glu189*)</td><td><list id="l0055" list-type="simple"><list-item id="li0230"><label>•</label><p id="p0230">1 male</p></list-item><list-item id="li0235"><label>•</label><p id="p0235">Early onset (in utero) recurrent fractures of vertebrae and extremities</p></list-item><list-item id="li0240"><label>•</label><p id="p0240">Bone deformity</p></list-item><list-item id="li0245"><label>•</label><p id="p0245">Short stature</p></list-item></list></td></tr><tr><td></td><td>c.893 T &gt; G (p.Phe298Cys)</td><td><list id="l0060" list-type="simple"><list-item id="li0250"><label>•</label><p id="p0250">1 male, 2 females</p></list-item><list-item id="li0255"><label>•</label><p id="p0255">Early onset of recurrent fractures of extremities and vertebrae</p></list-item><list-item id="li0260"><label>•</label><p id="p0260">Bone deformity</p></list-item><list-item id="li0265"><label>•</label><p id="p0265">Short stature</p></list-item><list-item id="li0270"><label>•</label><p id="p0270">Faint blue sclera</p></list-item></list></td></tr><tr><td><xref ref-type="bibr" rid="bb0060">Pyott et al. (2013)</xref></td><td>c.893 T &gt; G (Phe298Cys)</td><td><list id="l0065" list-type="simple"><list-item id="li0275"><label>•</label><p id="p0275">1 male, 1 female</p></list-item><list-item id="li0280"><label>•</label><p id="p0280">Early onset of recurrent fractures</p></list-item><list-item id="li0285"><label>•</label><p id="p0285">Long-bone deformity.</p></list-item><list-item id="li0290"><label>•</label><p id="p0290">Blue sclera</p></list-item></list></td></tr><tr><td></td><td>c.884C &gt; A (p.Ser295*)</td><td><list id="l0070" list-type="simple"><list-item id="li0295"><label>•</label><p id="p0295">2 males</p></list-item><list-item id="li0300"><label>•</label><p id="p0300">Early onset of recurrent fractures of vertebrae and extremities</p></list-item><list-item id="li0305"><label>•</label><p id="p0305">Developmental delays</p></list-item><list-item id="li0310"><label>•</label><p id="p0310">Brain deformities (1 proband)</p></list-item><list-item id="li0315"><label>•</label><p id="p0315">Autism</p></list-item></list></td></tr><tr><td></td><td>c.287_300delAGTTCCGGAATCGC (p.Gln96Profs*54)</td><td><list id="l0075" list-type="simple"><list-item id="li0320"><label>•</label><p id="p0320">1 female</p></list-item><list-item id="li0325"><label>•</label><p id="p0325">Multiple fractures, including lumbar vertebrae</p></list-item><list-item id="li0330"><label>•</label><p id="p0330">Short stature</p></list-item><list-item id="li0335"><label>•</label><p id="p0335">Developmental delays</p></list-item><list-item id="li0340"><label>•</label><p id="p0340">Right ptosis</p></list-item></list></td></tr><tr><td><xref ref-type="bibr" rid="bb0050">Laine et al. (2013)</xref></td><td>c.884C &gt; A (p.Ser295*)</td><td><list id="l0080" list-type="simple"><list-item id="li0345"><label>•</label><p id="p0345">2 females</p></list-item><list-item id="li0350"><label>•</label><p id="p0350">Early onset multiple fractures, including vertebral compression</p></list-item><list-item id="li0355"><label>•</label><p id="p0355">Kyphoscoliosis</p></list-item><list-item id="li0360"><label>•</label><p id="p0360">Severe short stature</p></list-item><list-item id="li0365"><label>•</label><p id="p0365">Deformities of the long bones</p></list-item><list-item id="li0370"><label>•</label><p id="p0370">Intellectual disability</p></list-item><list-item id="li0375"><label>•</label><p id="p0375">Absence of speech (one of the probands)</p></list-item><list-item id="li0380"><label>•</label><p id="p0380">Neurological deformities</p></list-item><list-item id="li0385"><label>•</label><p id="p0385">Quadriplegic</p></list-item></list></td></tr><tr><td><xref ref-type="bibr" rid="bb0025">Fahiminiya et al. (2013)</xref></td><td>c.428G &gt; T (p.Cys143Phe)</td><td><list id="l0085" list-type="simple"><list-item id="li0390"><label>•</label><p id="p0390">1 male, 1 female</p></list-item><list-item id="li0395"><label>•</label><p id="p0395">Short stature</p></list-item><list-item id="li0400"><label>•</label><p id="p0400">Multiple long bone and vertebral compression fractures</p></list-item></list></td></tr><tr><td></td><td>c.287_300del (p.Gln96Profs)</td><td><list id="l0090" list-type="simple"><list-item id="li0405"><label>•</label><p id="p0405">1 female</p></list-item><list-item id="li0410"><label>•</label><p id="p0410">Short stature</p></list-item><list-item id="li0415"><label>•</label><p id="p0415">Multiple long bone and vertebral compression fractures</p></list-item></list></td></tr><tr><td><xref ref-type="bibr" rid="bb0030">Faqeih et al. (2013)</xref></td><td>c.990C &gt; A (p.Cys330*)</td><td><list id="l0095" list-type="simple"><list-item id="li0420"><label>•</label><p id="p0420">1 male</p></list-item><list-item id="li0425"><label>•</label><p id="p0425">Severe hypotonia</p></list-item><list-item id="li0430"><label>•</label><p id="p0430">Disfigured skull</p></list-item><list-item id="li0435"><label>•</label><p id="p0435">Bone deformities</p></list-item><list-item id="li0440"><label>•</label><p id="p0440">Recurrent chest infection.</p></list-item><list-item id="li0445"><label>•</label><p id="p0445">Early recurrent fractures</p></list-item><list-item id="li0450"><label>•</label><p id="p0450">Severe global developmental delay</p></list-item><list-item id="li0455"><label>•</label><p id="p0455">Short stature</p></list-item><list-item id="li0460"><label>•</label><p id="p0460">Seizures</p></list-item></list></td></tr><tr><td>Stephen et al. (2014)</td><td>c.525_536delCTTCGGCCGCCT (p.Phe176_Leu179del)</td><td><list id="l0100" list-type="simple"><list-item id="li0465"><label>•</label><p id="p0465">2 males, 5 females</p></list-item><list-item id="li0470"><label>•</label><p id="p0470">Early onset multiple fractures</p></list-item><list-item id="li0475"><label>•</label><p id="p0475">Bone deformity</p></list-item><list-item id="li0480"><label>•</label><p id="p0480">Short stature</p></list-item></list></td></tr></tbody></table><table-wrap-foot><fn><p>Gene mutation and phenotypic correlation of reported monoallelic, compound and biallelic WNT1 mutations.</p></fn></table-wrap-foot></table-wrap></p>
<p id="p0515">Autosomal dominant mutations have also been described (<xref ref-type="bibr" rid="bb0050">Laine et al., 2013</xref>; <xref ref-type="bibr" rid="bb0035">Keupp et al., 2013</xref>). Affected individuals have presented with fragility fractures and low bone density without extra-skeletal features, as in the family described here. This case report highlights the phenotypic spectrum of a heterozygous missense mutation in the WNT1 gene, in that the daughter had low-impact fractures in early childhood, whereas the father sustained traumatic fractures primarily in young adulthood.</p>
<p id="p0520">The differences in phenotypic expression of autosomal recessive and autosomal dominant WNT1 mutations points to a potential difference in disease pathogenesis for these two types of mutations. One possibility is that heterozygous missense mutations encode an aberrant protein that interferes with signaling by the wild type protein. Although much more severe phenotypes generally occur with biallelic mutations, there is usually no phenotype associated with heterozygous carriers in families with biallelic disease due to null mutations. This suggests that the product of only one wild type allele is sufficient for normal function, and that the mutation in our case is consistent with a dominant negative effect.</p>
<p id="p0525">A heterozygous missense mutation in WNT1 previously described in a Finnish family (p.Cys218Gly) is in close proximity to the mutation in our case (<xref ref-type="bibr" rid="bb0050">Laine et al., 2013</xref>). Both mutations occur within the highly conserved WNT1 motif at residues 218–227 of the protein (C-[KR]-C-H-G-[LIVMT]-SG-x-C) (<xref ref-type="fig" rid="f0005">Fig. 1</xref>) (<xref ref-type="bibr" rid="bb0050">Laine et al., 2013</xref>). Four of the ten affected members of the Finnish family had lumbar spine z-scores of −2.0 or less. The majority also had multiple vertebral fractures, low-impact peripheral fractures, and no extra-skeletal manifestations. A second family has also been described with dominantly inherited osteoporosis due to a heterozygous mutation in close proximity to the WNT motif (p.Arg235Trp) (<xref ref-type="bibr" rid="bb0035">Keupp et al., 2013</xref>). Affected members of this family had cortical and trabecular bone loss on high-resolution peripheral quantitative CT and history of recurrent fractures.<fig id="f0005"><label>Fig. 1</label><caption><p>Diagram of reported monoallelic and biallelic WNT1 mutations.</p><p>Ribbon and space-filling diagram of the WNT1 molecule, depicted as a white ribbon in the grey space-filling model. WNT1 is engaged with Frizzled (yellow ribbon). The two views represent 180° rotations along a vertical axis. The conserved WNT domain (amino acids 218–227) is depicted in blue. The positions of bi-allelic mutations are depicted in green. Pink and purple represent the positions of known mono-allelic mutations (purple designates mutations within the conserved WNT domain, as detailed in <xref ref-type="table" rid="t0010">Table 2</xref>). The white arrow points to the mono-allelic mutation described in the current report. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)</p></caption><alt-text id="al0005">Fig. 1</alt-text><graphic xlink:href="gr1"></graphic></fig></p>
<p id="p0530">Given the emerging understanding of bone disorders associated with mutations in WNT1, therapies specifically targeting this signaling pathway offer potential therapeutic benefit. Clinical trials with a humanized anti-sclerostin antibody which activates WNT signaling have shown beneficial effects on bone mineral density as well as significant fracture risk reduction in patients with osteoporosis (<xref ref-type="bibr" rid="bb0045">Krause et al., 2010</xref>; <xref ref-type="bibr" rid="bb0020">Cosman et al., 2016</xref>). Other agents that enhance Wnt signaling, such as an anti-Dkk-1 antibody and SFRP inhibitors, continue to to be evaluated for clinical efficacy (<xref ref-type="bibr" rid="bb0040">Kim et al., 2013</xref>).</p>
<p id="p0535">In summary, we identified two family members with low bone mass and fractures associated with a heterozygous missense mutation in the WNT1 gene. This specific mutation (p.Gly222Arg) has not been previously described, but occurs in a highly conserved region of the WNT1 molecule and is in close proximity to the Frizzled binding site.</p>
</sec>
<sec id="s0020">
<title>Funding source</title>
<p id="p0540">R01 GM112182 (Dan Wu, PhD).</p>
</sec>
<sec id="s0025">
<title>Financial disclosure</title>
<p id="p0545">The authors have no financial relationships relevant to this article to disclose.</p>
</sec>
<sec id="s0030">
<title>Conflict of interest</title>
<p id="p0550">The authors have no conflicts of interest to disclose.</p>
</sec>
<sec id="s0035">
<title>Transparency document</title>
<p id="p0555">
<supplementary-material content-type="local-data" id="ec0005">
<caption>
<p>Transparency document.</p>
</caption>
<media xlink:href="mmc1.pdf">
<alt-text>Image 1</alt-text>
</media>
</supplementary-material>
</p>
</sec>
</body>
<back>
<ref-list id="bi0005">
<title>References</title>
<ref id="bb0005">
<element-citation id="rf0005" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aldinger</surname>
<given-names>K.A.</given-names>
</name>
<name>
<surname>Mendelsohn</surname>
<given-names>N.J.</given-names>
</name>
<name>
<surname>Chung</surname>
<given-names>B.H.</given-names>
</name>
</person-group>
<article-title>Variable brain phenotype primarily affects the brainstem and cerebellum in patients with osteogenesis imperfecta caused by recessive WNT1 mutations</article-title>
<source/>J. Med. Genet.
          <volume>53</volume>
<issue>6</issue>
<year>2016</year>
<fpage>427</fpage>
<lpage>430</lpage>
<pub-id pub-id-type="pmid">26671912</pub-id>
</element-citation>
</ref>
<ref id="bb0015">
<element-citation id="rf0015" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baron</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Kneissel</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>WNT signaling in bone homeostasis and disease: from human mutations to treatments</article-title>
<source/>Nat. Med.
          <volume>19</volume>
<issue>2</issue>
<year>2013</year>
<fpage>179</fpage>
<lpage>192</lpage>
<pub-id pub-id-type="pmid">23389618</pub-id>
</element-citation>
</ref>
<ref id="bb0020">
<element-citation id="rf0020" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cosman</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Crittenden</surname>
<given-names>D.B.</given-names>
</name>
<name>
<surname>Adachi</surname>
<given-names>J.D.</given-names>
</name>
</person-group>
<article-title>Romosozumab treatment in postmenopausal women with osteoporosis</article-title>
<source/>N. Engl. J. Med.
          <volume>375</volume>
<issue>16</issue>
<year>2016</year>
<fpage>1532</fpage>
<lpage>1543</lpage>
<pub-id pub-id-type="pmid">27641143</pub-id>
</element-citation>
</ref>
<ref id="bb0025">
<element-citation id="rf0025" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fahiminiya</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Majewski</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Mort</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Moffatt</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Glorieux</surname>
<given-names>F.H.</given-names>
</name>
<name>
<surname>Rauch</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Mutations in WNT1 are a cause of osteogenesis imperfecta</article-title>
<source/>J. Med. Genet.
          <volume>50</volume>
<issue>5</issue>
<year>2013</year>
<fpage>345</fpage>
<lpage>348</lpage>
<pub-id pub-id-type="pmid">23434763</pub-id>
</element-citation>
</ref>
<ref id="bb0030">
<element-citation id="rf0030" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Faqeih</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Shaheen</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Alkuraya</surname>
<given-names>F.S.</given-names>
</name>
</person-group>
<article-title>WNT1 mutation with recessive osteogenesis imperfecta and profound neurological phenotype</article-title>
<source/>J. Med. Genet.
          <volume>50</volume>
<issue>7</issue>
<year>2013</year>
<fpage>491</fpage>
<lpage>492</lpage>
<pub-id pub-id-type="pmid">23709755</pub-id>
</element-citation>
</ref>
<ref id="bb0035">
<element-citation id="rf0035" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Keupp</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Beleggia</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Kayserili</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Mutations in WNT1 cause different forms of bone fragility</article-title>
<source/>Am. J. Hum. Genet.
          <volume>92</volume>
<issue>4</issue>
<year>2013</year>
<fpage>565</fpage>
<lpage>574</lpage>
<pub-id pub-id-type="pmid">23499309</pub-id>
</element-citation>
</ref>
<ref id="bb0040">
<element-citation id="rf0040" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>J.H.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Wnt signaling in bone formation and its therapeutic potential for bone diseases</article-title>
<source/>Ther. Adv. Musculoskelet. Dis.
          <volume>5</volume>
<issue>1</issue>
<year>2013</year>
<fpage>13</fpage>
<lpage>31</lpage>
<pub-id pub-id-type="pmid">23514963</pub-id>
</element-citation>
</ref>
<ref id="bb0045">
<element-citation id="rf0045" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krause</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Korchynskyi</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>de Rooij</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Distinct modes of inhibition by sclerostin on bone morphogenetic protein and Wnt signaling pathways</article-title>
<source/>J. Biol. Chem.
          <volume>285</volume>
<issue>53</issue>
<year>2010</year>
<fpage>41614</fpage>
<lpage>41626</lpage>
<pub-id pub-id-type="pmid">20952383</pub-id>
</element-citation>
</ref>
<ref id="bb0050">
<element-citation id="rf0050" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Laine</surname>
<given-names>C.M.</given-names>
</name>
<name>
<surname>Joeng</surname>
<given-names>K.S.</given-names>
</name>
<name>
<surname>Campeau</surname>
<given-names>P.M.</given-names>
</name>
</person-group>
<article-title>WNT1 mutations in early-onset osteoporosis and osteogenesis imperfecta</article-title>
<source/>N. Engl. J. Med.
          <volume>368</volume>
<issue>19</issue>
<year>2013</year>
<fpage>1809</fpage>
<lpage>1816</lpage>
<pub-id pub-id-type="pmid">23656646</pub-id>
</element-citation>
</ref>
<ref id="bb0055">
<element-citation id="rf0055" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Makitie</surname>
<given-names>R.E.</given-names>
</name>
<name>
<surname>Haanpaa</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Valta</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Skeletal characteristics of WNT1 osteoporosis in children and young adults</article-title>
<source/>J. Bone Miner. Res.
          <volume>31</volume>
<issue>9</issue>
<year>2016</year>
<fpage>1734</fpage>
<lpage>1742</lpage>
<pub-id pub-id-type="pmid">27005318</pub-id>
</element-citation>
</ref>
<ref id="bb0060">
<element-citation id="rf0060" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pyott</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Tran</surname>
<given-names>T.T.</given-names>
</name>
<name>
<surname>Leistritz</surname>
<given-names>D.F.</given-names>
</name>
</person-group>
<article-title>WNT1 mutations in families affected by moderately severe and progressive recessive osteogenesis imperfecta</article-title>
<source/>Am. J. Hum. Genet.
          <volume>92</volume>
<issue>4</issue>
<year>2013</year>
<fpage>590</fpage>
<lpage>597</lpage>
<pub-id pub-id-type="pmid">23499310</pub-id>
</element-citation>
</ref>
<ref id="bb0065">
<element-citation id="rf0065" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stephen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Girisha</surname>
<given-names>K.M.</given-names>
</name>
<name>
<surname>Dalal</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Mutations in patients with osteogenesis imperfecta from consanguineous Indian families</article-title>
<source/>Eur. J. Med. Genet.
          <volume>58</volume>
<issue>1</issue>
<year>2015</year>
<fpage>21</fpage>
<lpage>27</lpage>
<pub-id pub-id-type="pmid">25450603</pub-id>
</element-citation>
</ref>
<ref id="bb0010">
<element-citation id="rf0010" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>van Amerongen</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Mikels</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Nusse</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Alternative wnt signaling is initiated by distinct receptors</article-title>
<source/>Sci. Signal.
          <volume>1</volume>
<issue>35</issue>
<year>2008</year>
<fpage>re9</fpage>
<pub-id pub-id-type="pmid">18765832</pub-id>
</element-citation>
</ref>
<ref id="bb0070">
<element-citation id="rf0070" publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Won</surname>
<given-names>J.Y.</given-names>
</name>
<name>
<surname>Jang</surname>
<given-names>W.Y.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>H.R.</given-names>
</name>
</person-group>
<article-title>Novel missense loss-of-function mutations of WNT1 in an autosomal recessive osteogenesis imperfecta patient</article-title>
<source/>Eur. J. Med. Genet.
          <volume>60</volume>
<issue>8</issue>
<year>2017</year>
<fpage>411</fpage>
<lpage>415</lpage>
<pub-id pub-id-type="pmid">28528193</pub-id>
</element-citation>
</ref>
</ref-list>
<fn-group>
<fn fn-type="supplementary-material" id="s0040">
<p id="p0560">The <ext-link ext-link-type="uri" id="ir0005" xlink:href="https://doi.org/10.1016/j.bonr.2018.09.001">Transparency document</ext-link> associated with this article can be found, in online version.</p>
</fn>
</fn-group>
</back>
</article>
</pmc-articleset>